Chiome Bioscience Inc. announced non-consolidated earnings results for the year ended December 31, 2018. For the full year, the company reported net sales of ¥212 million against ¥259 million a year ago. Operating loss was ¥1,539 million against ¥887 million a year ago. Net loss was ¥1,533 million against ¥882 million a year ago. Net loss per share was ¥57.26 against ¥33.48 a year ago.